And the before and after results database shows what real-world outcomes look like beyond clinical trial averages
Microdosing GLP-1s for cosmetic weight loss: Patients are asking me about it, TV and online ads are promoting it, friends are speculating about whos doing it
It should not be interpreted as usage advice, preparation guidance, administration guidance or personal-use guidance
For pens, is the cap secure, and does the pen mechanism function properly
Add 10 grams of fiber daily for two weeks and reassess
Key Takeaway: Tirzepatide targets two metabolic receptors (GLP-1/GIP) to offer up to 20.9% average weight loss, while Retatrutide attacks fat storage via three pathways (GLP-1/GIP/Glucagon), yielding unprecedented weight loss averages near 24.2% in Phase 2 trials